COMMUNIQUÉS West-GlobeNewswire
-
Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and Beyond
18/08/2026 -
BrewDog Unwraps Its 2026 Advent Calendar
18/08/2026 -
AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes
18/08/2026 -
PROMIXX Pursuit Insulated Shaker Bottle Keeps Protein Shakes Ice Cold for 12+ Hours, Outlasting Standard Gym Bottles
18/08/2026 -
Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation
18/08/2026 -
Quantum-Si to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
18/08/2026 -
Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch
18/08/2026 -
Eyconis Announces Initiation of First-in-Human Clinical Trial of EYC-0305 in Treatment-Naïve Wet Age-Related Macular Degeneration Patients
18/08/2026 -
MediBeacon Transdermal GFR System Nominated for 2026 Prix Galien USA Best Medical Technology
18/08/2026 -
Board-Certified Vascular and Endovascular Surgeon Performs First Commercial Symvess® Implantation; Cites Bioengineered Blood Vessel as “Revolutionary Advancement”
18/08/2026 -
Noom Appoints Jim Bugden Chief Financial Officer as Company Enters Next Phase of Growth
18/08/2026 -
CRNA Coach Amanda Kay Launches $5 Live Bootcamp as The Mindful CRNA Expands Support for Nurses Entering Anesthesia
18/08/2026 -
SciSparc: Subsidiary NeuroThera Labs Completes C$5.4 Million Financing with SciSparc’s Stake Valued at Approximately C$30 Million
18/08/2026 -
Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom
18/08/2026 -
Pliant Therapeutics Receives FDA Fast Track Designation for PLN-101095 in Combination with Pembrolizumab for the Treatment of ICI-Refractory Solid Tumors
18/08/2026 -
Vivos Inc. Achieves Two Major Operational Milestones: First IsoPet® Shipments from New U.S. Production Facility and Authorization from India’s Nuclear Regulatory Authority for International Manufacturing Center
18/08/2026 -
Propanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP
18/08/2026 -
ENvue Medical Announces Exclusive UroShield® Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million
18/08/2026 -
Polomar Health Services Reports Second-Quarter Revenue of $1.53 Million and Positive Net Income
18/08/2026
Pages